Literature DB >> 3516194

Antitumour activity of platinum analogues against human yolk sac tumours heterotransplanted in nude mice.

M Sawada, Y Matsui, Y Okudaira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3516194      PMCID： PMC2001349          DOI： 10.1038/bjc.1986.68

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  9 in total

1.  Human Yolk Sac Tumor of the Ovary Serially Heterotransplanted in nude mice.

Authors:  M Sawada; K Hayakawa; H Nishiura; Y Matsui; S Tanabe
Journal:  Gynecol Oncol       Date:  1981-02       Impact factor: 5.482

2.  Human gynecologic cancers heterotransplanted into athymic nude rats.

Authors:  M Sawada; Y Matsui; K Hayakawa; H Nishiura; Y Okudaira; I Taki
Journal:  Gynecol Oncol       Date:  1982-04       Impact factor: 5.482

3.  Preclinical studies on toxicity, antitumour activity and pharmacokinetics of cisplatin and three recently developed derivatives.

Authors:  P Lelieveld; W J Van der Vijgh; R W Veldhuizen; D Van Velzen; L M Van Putten; G Atassi; A Danguy
Journal:  Eur J Cancer Clin Oncol       Date:  1984-08

4.  Phase I clinical trial of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) (CHIP).

Authors:  P J Creaven; S Madajewicz; L Pendyala; A Mittelman; E Pontes; M Spaulding; S Arbuck; J Solomon
Journal:  Cancer Treat Rep       Date:  1983-09

5.  Establishment of a new ovarian tumor line in nude mice and its application to treatment of the donor patient.

Authors:  M Sawada; Y Matsui; Y Okudaira
Journal:  Gynecol Oncol       Date:  1985-07       Impact factor: 5.482

6.  Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

Authors:  A H Calvert; S J Harland; D R Newell; Z H Siddik; A C Jones; T J McElwain; S Raju; E Wiltshaw; I E Smith; J M Baker; M J Peckham; K R Harrap
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

7.  Chemotherapy of human yolk sac tumor heterotransplanted in nude mice.

Authors:  M Sawada; Y Matsui; Y Okudaira
Journal:  J Natl Cancer Inst       Date:  1983-12       Impact factor: 13.506

8.  Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma.

Authors:  B D Evans; K S Raju; A H Calvert; S J Harland; E Wiltshaw
Journal:  Cancer Treat Rep       Date:  1983-11

9.  Criteria for the selection of second-generation platinum compounds.

Authors:  R Shepherd; H Kusnierczyk; M Jones; K R Harrap
Journal:  Br J Cancer       Date:  1980-11       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.